Actively Recruiting
Tumor-Derived FGF19
Led by University of Central Florida · Updated on 2024-12-06
210
Participants Needed
1
Research Sites
103 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Identify and test thresholds, specificity and sensitivity for a potential cancer associated biomarker protein, FGF19, (and associated markers) for detection in human blood in the blood of breast and colorectal in cancer patients, and see if occurs at higher rates than healthy controls
CONDITIONS
Official Title
Tumor-Derived FGF19
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult persons with breast cancer, colorectal cancer, or healthy controls
- Able to provide a fasting blood draw
- Pregnant women may participate as study procedures do not pose risks to them or their unborn child
You will not qualify if you...
- Unable or unwilling to provide informed consent
- Adults unable to consent, individuals who are not adults, and prisoners
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Burnett School Biomedical Sciences
Orlando, Florida, United States, 32816
Actively Recruiting
Research Team
A
Amoy Fraser, PhD, CCRP, PMP
CONTACT
E
Erica Martin, B.S.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here